A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects
Clinical trial NCT04993222 · COMPLETED
Trial details
- NCT number
- NCT04993222
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-04
- Primary completion
- 2020-09-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.